LPCE_Lab_Nice

Pathology|Biobank|S96-900 certified| ISO 15189 accreditation| Thoracic diseases| Thyroid | Melanoma| Dedicated to implement clinical innovation| Research

[LPCE_Lab_Nice @LPCE_Nice]

@md_mariusilie @CHUdeNice @FacMedecine @FondationUCA Thank you Dr ARMON for choosing our lab 🔬

[Anirban Maitra @Aiims1742]

I am very happy to see this perspective on molecular subtypes of small cell #lungcancer in @NatureRevCancer - feels like a tribute to the late Adi Gazdar by many of his friends and colleagues.
@TGOliver2 @SageJulien @UTSWNews
https://t.co/u7qg2jpOIG

[Marseille Immunopole @Immunopole]

The @icgc_dcc has launched its new data portal, a user-friendly platform for efficient visualization, analysis and interpretation of its comprehensive catalog of #mutations in the major #tumor types @NatureBiotech https://t.co/Pzmo4Gt1of https://t.co/utMK9my6sV

[IRCAN @ircaninstitute]

Paul Hofman presents the work of his lab at @ircaninstitute 's retreat #live

[ESMO - Eur. Oncology @myESMO]

On #InternationalWomansDay read the editorial from ESMO President @TaberneroJosep on 'All change: closing the gender gap in oncology' https://t.co/ECnApGJj9Y

[Anirban Maitra @Aiims1742]

In a companion review in @NatureMedicine @VanAllenLab et al @DanaFarber @broadinstitute detail genomic correlates of cancer #immunotherapy
https://t.co/MCSMP83g5r
Great summary tables on correlates & trials

[Julien Mazieres @JulienMazieres]

On vous attend à Toulouse pour 4 jours dédiés à l’oncologie thoracique dans un cadre agréable.

[LPCE_Lab_Nice @LPCE_Nice]

Management Review Meeting @LPCE_Nice @BBMRIERIC @BIOBANQUES #teamwork @CHUdeNice Training @uca_education They trust us @TransHitBio @theNCI @UniCancer_LeonB

[H. Jack West, MD, FASCO @JackWestMD]

Interesting article w/converging evidence for TMB predictive utility for IO here a new blood-based test:
AssessmentTumor Mutational Burden as a Potential Biomarker for Immunotherapy in Non–Small Cell Lung Cancer https://t.co/QPYWYUJJnY

#LCSM

[LPCE_Lab_Nice @LPCE_Nice]

@LPCE_Nice

[Jen Heemstra @jenheemstra]

There’s a huge difference between being busy and being productive:
Being busy = doing lots of things
Being productive = doing the most important things in the best possible way

Busyness fools you into thinking you’re making progress, but productivity actually moves you forward.

[LPCE_Lab_Nice @LPCE_Nice]

Soon to welcome international students in Biobanking. Until then, FFPE clearance before WE #Immunotherapy #LCSM

[AACR @AACR]

RT @CCR_AACR: Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers. https://t.co/65V3jdPnhb

[H. Jack West, MD, FASCO @JackWestMD]

Some pts have sustained benefit even after D/C of IO-induced great response.

However, shouldn't presume pts will do better by forcing CR by "intensification" (RT? surgery?) not achieved otherwise. Like trying sex change for men after noting women have better cancer outcomes.

[Gil Morgan, MD @weoncologists]

French #cancer trial published at @TheLancetOncol shows #Immunotherapy nivolumab monotherapy or nivolumab+ipilimumab combo has promising activity in relapsed patients with #malignant pleural #mesothelioma, without unexpected #toxicity. https://t.co/I063Qvv89D

[Anirban Maitra @Aiims1742]

The rest of the commentary. Thanks to @FAndreMD & @Annals_Oncology for publishing. Written in honor of cancer patients who bravely go on early phase clinical trials & the oncologists who conduct these trials on a daily basis.